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 
Aim: Is modulation of skeletal muscle capillary supply by altering blood flow due to a 
presumptive shear stress response  , or dependent on the vasodilator mechanism? 
Methods: The response to four different vasodilators, and cotreatment with blockers 
of NO and prostaglandin synthesis, were compared. Femoral artery blood flow was 
correlated with capillary to fibre ratio (C:F), and protein levels of putative angiogenic 
compounds. 
Results: All vasodilators induced a similar increase in blood flow after 14 days, with a 
similar effect on C:F (1.62±0.05, 1.60±0.01, 1.57±0.06, 1.57±0.07, respectively, all 
+<0.05 . control 1.20±0.01). Concomitant inhibitors revealed differential effects on 
blood flow and angiogenesis, demonstrating that a similar response may have 
different signalling origins. The time course of this response with the most commonly 
used vasodilator, prazosin, showed blood flow increased from 0.40 ml.min1 to 0.61 
ml.min1 by 28 days (+<0.05), dropped within 1 week after cessation of treatment 
(0.54 ml.min
1
; +<0.05) and returned to control levels by 6 weeks. In parallel with 
FBF capillary rarefaction began within 1 week (+<0.05), giving C:F values similar to 
control by 2 weeks. Of the dominant signalling pathways, prazosin decreased muscle 
VEGF but increased its cognate receptor Flk1 (both +<0.01), levels of eNOS varied 
with blood flow (+<0.05), Ang1 initially increased while its receptor Tie2 was 
unchanged, with only modest changes in the antiangiogenic factor TSP1. 
Conclusion: Hyperaemiainduced angiogenesis, likely in response to elevated shear 
stress, is independent of the vasodilator involved, with a rapid induction and quick 
regression following stimulus withdrawal.  
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
Angiogenesis is the postnatal mechanism whereby an existing microvascular network 
is expanded in response to a changing metabolic and mechanical environment 
(Hudlická et al., 1992). For example, endurance exercise increases haemodynamic 
forces within skeletal muscle microcirculation accompanying the functional 
hyperaemia and deformation of blood vessels during a duty cycle (Egginton, 2009). 
Vasoactive metabolites mediate arteriolar vasodilatation, and the accompanying 
increase in vascular conductance is a major stimulus for exerciseinduced 
angiogenesis (Prior et al., 2004). As capillaries have low compliance, elevated 
microvascular perfusion leads to an elevated capillary shear stress, as confirmed by 
intravital microscopy observations (Hudlická et al., 1992). Canonical, sprouting 
angiogenesis is invoked by increased muscle activity (Hudlická et al., 1992, Hansen
Smith et al., 1996). However, physiological angiogenesis may also occur through 
capillary splitting, intussusception, and elongation, in response to a number of 
different stimuli (Egginton et al., 2001). 
Orally administered vasodilators may expand the microvascular bed (Hudlická, 
1998), and chronic treatment stimulates a specific form of angiogenesis termed 
longitudinal splitting (Egginton et al., 2001).  Muscle capillary neoformation occurs 
in rats treated with dipyridamole (Tornling et al., 1980), and in rabbits treated with 
adenosine or with propentofylline (Ziada et al., 1984), but the α1adrenoreceptor 
antagonist prazosin offers a targetted increase in capillarisation of skeletal muscle due 
to the differential adrenoreceptor receptor density among tissues (Hudlická, 1998) 
(Baum et al., 2004). Other vasoactive drugs have been less effective, likely due to 
second order effects on either cardiac or skeletal muscle. For example, treatment with 
nitroglycerine (an NO donor), diltiazem (a calcium channel blocker), or propranolol 
(a nonselective betablocker) did not affect the capillary to fibre ratio  (C:F) in rat 
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EDL or soleus (Torres et al., 1994). An important question is, therefore, whether the 
mechanism of vasodilatation affects the extent of shear stressinduced angiogenesis. 
During development and adaptive remodelling in adult organs, newly grown blood 
vessels are often pruned to optimise functional capacity of the microcirculation, a 
process known as angioadaptation (Zakrzewicz et al., 2002). Vascular remodelling 
after withdrawal of a specific angiogenic stimulus has not been widely studied, 
although a decrease in capillary supply may follow reduced muscle activity, e.g. a 
6.3% reduction in capillary density in longdistance runners only two weeks after 
stopping training (Houston et al., 1979), and more recently in exercise trained mice 
where a complex pattern of pro and antiangiogenic factor changes was observed 
(Olenich et al., 2014). The speed of vascular regression is important as it may 
influence progression of impaired function associated with e.g. bed rest and use of 
angiotherapies. Existing animal models of vessel regression (e.g. muscle denervation, 
limb suspension, tenotomy) all have limitations when determining the speed of 
regression. For example, studies in skeletal muscle with disuse atrophy following 
hindlimb unloading demonstrate a decrease in blood flow (McDonald et al., 1992), 
capillary luminal diameter and C:F (Kano et al., 2000), despite an increase in 
capillary density (Tyml et al., 1999), probably because the rate of muscle atrophy was 
greater than that of capillary regression. While some studies have explored changes in 
gene expression and protein levels during shear stressinduced angiogenesis (Wragg 
et al., 2014), little attention has focused on the physiological response to cessation of 
vasodilator treatment and subsequent capillary regression. Here, we explore the 
effects of chronic increase in blood flow, and examined how quickly the 
microcirculation reverts to pretreatment levels once the angiogenic stimulus is 
removed. 
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Studies examining the molecular pathways involved in endothelial 
mechanotransduction of haemodynamic stimuli have largely focused on VEGF and 
NO, as these regulate shearmediated angiogenesis in a spatiotemporal manner 
(Egginton, 2011). VEGF is vital in physiological angiogenesis: its blockade results in 
the absence of capillary growth following chronic hyperaemia or muscle overload 
(Williams et al., 2006a, Williams et al., 2006c, Uchida et al., 2015). VEGF and its 
receptor VEGFR2 are upregulated by elevated shear stress, with peak expression 
preceding the increase in capillarisation (Milkiewicz et al., 2006). Pharmacological 
blockade of NOS isoforms, or genetic ablation of eNOS but not nNOS, also led to 
suppression of prazosininduced angiogenesis (Williams et al., 2006a). Increased 
shear stress associated with tissue hyperaemia leads to release of NO and 
prostaglandins, in particular prostacyclin (PGI2). Blockade of prostaglandin synthesis 
by indomethacin likewise attenuates angiogenesis that accompanies increased muscle 
activity due to electrical stimulation (Pearce et al., 2000). It is therefore unclear 
whether different forms of vasodilatation are differentially sensitive to blockade of 
NO or prostaglandin production.  
We tested the hypothesis that the mechanism of vasodilatation does not determine 
the extent of shear stressinduced angiogenesis, and vasodilators have no direct 
angiogenic effects 		 independent of blood flow. To achieve this, we used four 
different vasodilators, and inhibited NO and prostacyclin production, two archetypal 
downstream mediators of vascular tone and blood flow.  Given the low mitotic 
activity associated with this form of angiogenesis (Egginton, 2011), we reasoned that 
the time course of microvascular growth and regression after vasodilator treatment 
was stopped would be short. Finally, we determined expression levels of some key 
regulatory factors to establish potential signalling pathways. The findings may be 
important in developing effective shortacting angiotherapies. 
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

,	

All work was performed in accordance with the UK Animal (Scientific Procedures) 
Act 1986. The procuration of animals, the husbandry and the experiments conform to 
the 'European Convention for the Protection of Vertebrate Animals used for 
Experimental and other Scientific Purposes' (Council of Europe No 123, Strasbourg 
1985). Male C57/BL10 mice at least 6 wk old (from Harlem or Charles River, UK; 
body mass 23.5±0.4g, n=46 per group) were housed at 21˚C with a 12:12 light:dark 
cycle. Males were chosen in order to avoid confounding influences on vasculature 
remodelling accompanying the estrus cycle. All animals were kept in an enriched 
environment and given standard laboratory feed and water 	*	$
-
 
,
					
 $
All vasodilator drugs were given in drinking water for a period of 14 d: prazosin (α1 
adrenoreceptor antagonist, 50mg.l
1
), verapamil (Ltype calcium channel inhibitor, 
35mg.l1), cromakalim (KATP channel opener, 1mg.l
1), and ethanol (impairs actin
myosin interaction and decreases cytosolic–free Ca2+ in arteriolar smooth muscle, 3%; 
(Zhang et al., 1992)). Potential haemodynamic effects of vasodilators were minimised 
by choosing doses based on previous literature, and pilot studies. The lack of any 
significant change in blood pressure or heart rate suggests regional dilatation was 
compensated elsewhere in the cardiovascular system, so the effects on e.g. cardiac 
output are likely to be small. The nonspecific nitric oxide synthase (NOS) inhibitor 
NwnitroLarginine  (LNNA, 100mg.l
1) or nonselective inhibitor of 
cyclooxygenase 1 and 2, indomethacin (50mg.l
1
) were used in each of the vasodilator 
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7
groups to elucidate the possible roles that NO and prostaglandin may play in shear 
stressinduced angiogenesis, respectively. Inhibitor treatment was concurrent with 
vasodilator treatment. Previous studies from our group using individual vasodilators 
in rats (all experiments exploring the mechanisms of angiogenesis have yielded 
closely similar results in rats and mice) showed no significant effects of these 
inhibitors alone (Pearce et al., 2000, Williams et al., 2006a), as expected given the 
low basal NO and prostaglandin expression. 
 
	
$	  
In previous studies (Williams et al., 2006a) a steady state capillarisation was reached 
by 4 wk prazosin treatment. Mice were therefore given vasodilators in drinking water 
and sampled at 2, 4, 7, 14 and 28 d, after which treatment was ended and the mice 
were given access to untreated drinking water. Groups of mice were then sampled 3, 
7, 14, 28 and 42 d after cessation of treatment. 
 

		

Mice were anaesthetised i.p. with ketamine (0.1 mg/kg, Pharmacia) and xylazine 
(0.01 mg/kg, Millpledge Pharmaceuticals, UK), with core temperature controlled by a 
heating pad. Arterial blood pressure (ABP) and heart rate were measured as described 
previously (Williams et al., 2006a). Briefly, the right carotid artery was cannulated 
(PP10) for ABP measurements, and the trachea cannulated (PP50) to aid spontaneous 
ventilation. A perivascular flow probe (Transonic 0.5VB, Linton Instrumentation, 
Norfolk, UK) on the upper portion of the femoral artery, adjusted to minimise strain, 
was used to record hindlimb blood flow. Previous studies have demonstrated a clear 
relationship between hindlimb blood flow and individual muscle blood flow in rats 
(Hargreaves et al., 1990, Hudlická and Brown, 2009). All recordings were made with 
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PowerLab (AD Instruments, Oxford) and LabChart software. The procedure took <1h 
to minimise dehydration or the need for further anaesthesia. 
 
.	
	
Animals were killed by cervical dislocation before the 
-/	"	$
"$ 
(EDL; a mixed fast muscle) was dissected and snapfrozen in liquid nitrogencooled 
isopentane. 10µm cryosections were prepared and allowed to airdry at room 
temperature (RT). Capillary staining was performed at RT for 30 min on cool 
acetonefixed secti ns using rhodamineconjugated 0		 	
 			 lectin1 
(Vector; 1:200). Cell proliferation was measured using proliferating cell nuclear 
antigen (PCNA, Santa Cruz; 1:100,). Sections were incubated with secondary 
antibody (1:50 CY2 conjugated donkey antirabbit, Jackson, and 1:100 rhodamine 
conjugated GSL1 lectin, Vector) to identify sites of capillaryassociated cell 
proliferation. Sections were rinsed and mounted in glycerol. Terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining to measure 
cell apoptosis was carried out following manufacturer’s instructions (Invitrogen). 
Briefly, Proteinase K solution was applied to airdried sections, and following wash 
and quenching, transferred into TdT reaction mix. Slides were incubated at 37°C and 
developed using streptavidinHRP detection developed with DAB solution, 
counterstained with methyl green, cleared in xylene and mounted in Histomount 
(Invitrogen). Sections were viewed under fluorescent illumination (Zeiss Axioskop 2 
microscope) using proprietary software (Axiovision, Zeiss), and images captured on 
an MRc digital camera. Capillaries and fibres were counted as previously described 
(Egginton, 1990a, Egginton, 1990b). Briefly, four nonoverlapping images were taken 
per section, each in the same relative position and equally spaced, and a square lattice 
counting frame (area 0.194 mm2) superimposed at a total magnification of x250. 
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Although capillary supply to the muscle may be expressed as either capillary density 
(mm2) or as capillary to fibre ratio (C:F), the latter is less sensitive to modest inter
animal variability in fibre size (Egginton, 1990a), and was therefore used throughout 
as an index of angiogenic activity. It was not logistically possible to include time
controls for all points, but we have previously conducted such controls for up to 14 
day treatment (Williams et al., 2006a) with no significant change in C:F.  
 
	
	 
SDSPAGE was used for electrophoretic analysis of proteins, following standard 
western blotting techniques. Briefly, samples were snapfrozen and crushed in liquid 
nitrogen, and homogenised in RIPA lysis buffer with added protease inhibitors (1mM 
P.I.C; 1mM PMSF; 1mM Na3Vo4; Sigma) for extraction. Protein concentration was 
estimated using bovine serum albumin as a standard. Samples were run 
simultaneously with equal protein loading (100µg/lane) at 4°C (150V, 1h; BioRad), 
transferred onto polyvinylidene membranes (100V, 12h; BioRad) on ice. Non
specific protein binding was blocked with 1% milk and probed with primary 
antibodies (overnight at 4°C), then incubated with secondary antibodies (typically 
1:5,000 for 1h at RT; Jackson goatanti mouse cat#115085166, goatanti rabbit 
cat#111035144) and visualised by enhanced chemiluminscence (ECL Femto; 
Pierce). The following primary antibodies were used: eNOS(1:200, BD Transduction 
Laboratories, cat#610293), VEGF (1:500, Santa Cruz Biotechnology, cat#SC57496), 
Flk1 (1:500; Santa Cruz Biotechnology, cat#SC504), Ang1 (1:500, Rockland, 
cat#100401403), Tie2 (1:1000, R&D Systems, cat#AF762), TSP1 (1:1000, R&D 
Systems, cat#AF3074). All other materials were from Sigma Aldrich, UK, unless 
otherwise stated. ImageJ software (NIH) was used to quantify relative protein levels 
from densitometric analysis of photosensitive film (Amersham). Total protein was 
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quantified (MemCode Reversible Stain; Pierce), and successful protein transfer 
confirmed using Coomassie stain of membranes (Pierce). 
 
			
All data are presented as mean ± S.E.M. Statistical significance between groups was 
established using ANOVA with Fishers’ PLSD post hoc test using a 5% significance 
level. 
 


		 
Heart rate and blood pressure remain unaltered during drug treatment, despite 
increases in hindlimb blood flow as a consequence of local vasodilatation 
(Supplementary Table 1), suggesting that the reduced peripheral resistance was 
adequately compensated by an increased cardiac output (i.e. an effective baroreceptor 
reflex). There was some increase in body mass during the course of extended 
treatment, an expected consequence of increased age, but the relative EDL, tibialis 
anterior and soleus muscle masses were similar across all groups (0.037±0.002, 
0.159±0.002 and 0.027±0.001% body mass, respectively; n.s. among groups and for 
time). 
 
		
		 		
	1
Compared to controls (0.40±0.01 ml.min1), a significantly greater femoral blood flow 
(FBF) was seen for prazosin (0.59±0.0.02 ml.min1), verapamil (0.59±0.02 ml.min1), 
cromakalim (0.57±0.01 ml.min1) and ethanol (0.59±0.03 ml.min1) treated mice after 
14 d (all +<0.01; Fig. 1A). A significantly higher C:F was seen in EDL of prazosin 
(1.62±0.05), verapamil (1.60±0.01), cromakalim (1.57±0.06), and ethanol (1.57±0.07) 
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treated mice (all +<0.001 - control of 1.20±0.01,  Fig. 1B). As blood flow velocity 
and microvascular diameter were not measured, ‘shear stressinduced angiogenesis’ is 
an assumption based on extrapolation from previous studies from our group that 
gathered such data (e.g. (Hudlická and Brown, 2009)). Electron microscope images 
taken after 14 d of treatment revealed that capillaries from the four vasodilatory 
groups displayed a control phenotype, indicating that little or no angiogenesis was 
occurring at this time point; i.e. no luminal processes, no vacuolisation, and no 
thinning of the basement membrane ( (Williams et al., 2006a); data not shown), 
suggesting that active angiogenesis was complete by 14 days. The increase in C:F was 
proportional to the increase in FBF among the different treatment groups (Fig. 2). We 
tested the effects of age on a few animals from later groups that suggested the small 
difference in C:F between control and 42DR was likely agerelated (data not shown). 
 
[Fig. 1 near here] 
 
[Fig. 2 near here] 
 
,	*		/	 "			*		
Following LNNA blockade of NOS activity, femoral blood flow for all vasodilator 
groups were either at (cromakalim, ethanol) or below (prazosin, verapamil) control 
levels (all +<0.001 - vasodilator alone; data not shown). With coadministration of 
indomethacin flow was reduced by 53% - prazosin alone, 56% - verapamil, 36% 
- cromakalim, and 46% - ethanol (all +<0.05; data not shown). 
With LNNA, C:F remained at control levels in prazosin (1.213±0.023) and 
verapamil (1.269±0.031) groups (both +<0.001 - vasodilator; n.s. - control), but 
with cromakalim (1.353±0.054) and ethanol (1.369±0.036) there was only a ~60% 
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lower C:F than with vasodilator alone (both +<0.05 - dilator and control). Co
administration of indomethacin with the various vasodilators led to a lower C:F in all 
groups compared with vasodilator alone: 73% reduction - prazosin (1.313±0.043, 
+<0.001), 36% reduction - verapamil (1.482±0.062, +<0.001), 63% reduction - 
cromakalim (1.340±0.024, +<0.05), and 23% reduction - ethanol (1.524±0.039, 
n.s.) (Fig. 3).  
In the cromakalim and ethanol groups, LNNA and indomethacin were also given 
in combination to assess the effects of dual inhibition of NO and prostaglandin 
synthesis. Then, C:F was not significantly different to control levels (1.210±0.007 and 
1.247±0.029, respectively). 
We conducted a few experiments (two animals for each) to check there were no 
obvious effects of the inhibitors alone on femoral blood flow, blood pressure and C:F 
(consistent with previous finding using rats). As with agematched controls these data 
are omitted as the statistical treatment was not robust due to small sample size. 
 
[Fig. 3 near here] 
 
	
 $  		
* * 2   3	$ "	"	 
 	"	 
Femoral blood flow (FBF) increased with length of prazosin treatment, and a positive 
correlation between FBF and C:F was seen up to 4 wk prazosin treatment (Fig. 4). 
After cessation of treatment, FBF was reduced from a peak of 0.59ml.min1 to 
0.54ml.min1 (+<0.05) within 7 d, and returned to control values 26 wk later.  
C:F of EDL increased within 1 wk of prazosin treatment with C:F reaching a 
presumed peak of 1.62±0.03 by 2 wk; this was maintained for the 4 weeks of 
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13
treatment. Within 1 wk after prazosin withdrawal, C:F approached control values in 
EDL (Fig. 4).  
 
[Fig. 4 near here] 
 
!	 *	
	 "	 	 
The prazosininduced rise in FBF was accompanied by a steady decline in EDL 
muscle VEGF protein from control levels (0.21±0.02) that continued after treatment 
was stopped and blood flow declined, reaching its lowest level at 14 d recovery 
(14DR) (0.14±0.02; +=0.058), but recovered to control levels after 6 wk (0.19±0.01, 
n.s.). During the same period, basal levels of VEGFR2 (Flk1) protein (0.14±0.02) 
rose to a peak at 4 wk prazosin treatment (0.25±0.06; +=0.117), and were maintained 
for some time after cessation of vasodilator treatment (6 wk postprazosin = 
0.24±0.03; n.s. - 4 wk prazosin). VEGFR1 (Flt1) levels mirrored those of Flk1 
(data not shown). Levels of eNOS protein increased with treatment, and continued to 
rise until 7DR (0.12±0.02 - control of 0.08±0.02; +<0.05). A subsequent decrease in 
eNOS expression followed the decline in FBF, returning to control values at 42DR 
(0.07±0.02; n.s.). Levels of eNOS varied inversely with respect to VEGF (Fig. 5).  
 
[Fig. 5 near here] 
 
Ang1 protein levels rose sharply from control values (0.13±0.02) to maximum at 
3DR (0.31±0.06; +=0.09; Fig. 6). A more gradual decline was then seen, but even by 
42DR expression had not reached control values (0.23±0.03). Conversely, TSP1 
levels decreased relative to control control from 14DP, and this decrease was 
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maintained until 42DR.  Levels of the Ang1 receptor, Tie2, did not change (n.s. - 
control). 
 
[Fig. 6 near here] 
 



4		
	"	"		 		
	
We demonstrate an increase in C:F of mouse EDL by ~30% with all vasodilators 
tested, accompanying a consistent increase in femoral blood flow (FBF) of ~45%. 
Reversal of these responses on withdrawal of vasodilator treatment demonstrates a 
positive correlation between hindlimb blood flow and muscle capillary supply. These 
data support the hypothesis that angiogenesis occurs primarily due to elevated 
microvascular shear stress, not an independent action of vasodilator compounds 
(Egginton et al., 2001). Interestingly, as the increase seen within the four vasodilator 
groups occurred to a similar level (C:F ~1.6), and capillary phenotype appeared 
similar to control at 14 d (unpublished data), the extent of angiogenesis could be the 
maximum inducible by elevated shear stress. A lack of statistical difference for C:F 
between 14DP and 28DP suggests there is an upper limit to skeletal muscle capillary 
supply (Snyder, 1987). The appearance of capillaries undergoing longitudinal splitting 
in mouse EDL following prazosininduced hyperaemia have previously been 
described, and the extent of angiogenesis varies with FBF, with a maximal response 
induced by 28 d (Williams et al., 2006a). This muscle was chosen because of its 
mixed fibre type composition, so qualitatively, but not quantitatively similar effects 
may be expected in other muscles. The rapidity of response in both growth and 
rarefaction is consistent with capillary splitting being energetically efficient compared 
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with the more common sprouting angiogenesis, as evidenced by the low proliferation 
labelling index of endothelial cells (Egginton, 2011). 
 
		/		"	"	
Nitric oxide (NO), generated by nNOS in muscle fibres (Balon and Nadler, 1994) or 
eNOS in blood vessel endothelium in response to increased shear stress (Fleming and 
Busse, 2003), contributes to the hyperaemia observed during acute muscle 
contractions in animals (Hirai et al., 1994) and humans (Boushel, 2003, Schrage et al., 
2004). Both isoforms can be upregulated when muscle activity is increased longterm 
by electrical stimulation (nNOS; (Reiser et al., 1997)) or exercise training (eNOS; 
(Sun et al., 1994)). NO contributes to the basal tone and diameter of arterioles in rat 
skeletal muscle (Kaley et al., 1992, Friebel et al., 1995) and to the dilatation of small 
arterioles during acute contractions (Cohen et al., 2000). 
Complete inhibition of angiogenesis by LNNA was seen in two of the four 
vasodilator groups (prazosin, verapamil), where hindlimb blood flow was slightly 
below control levels, strongly suggesting that the role of NO in shearinduced 
angiogenesis is as a vasodilator. Similarly, LNNA inhibition of NOS in rats 
abolished the increase in measured shear stress (Hudlická et al., 2006), along with cell 
proliferation and capillary growth in electrically stimulated muscles (Milkiewicz et 
al., 2001). We therefore speculate that the angiogenesis caused by prazosin and 
verapamil was a consequence of NOdependent increase in flow. In the remaining two 
groups (cromakalim, ethanol) LNNA only partially inhibited the increase in C:F, and 
with FBF at control levels following NOS inhibition demonstrates the contribution of 
NOindependent stimulators of angiogenesis.  
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+"	"	"	
Prostaglandin production is involved in endothelial cell migration (Tsujii et al., 1998) 
and tubular network formation in 3D collagen gels (Milkiewicz et al., 2006). 
Prostacyclin (PGI2) (Frangos et al., 1985) and cyclooxygenaseII (COX2) (Topper et 
al., 1996) are released in response to an increase in shear stress, and modulate the 
expression of angiogenic genes within human endometrium (Gately and Li, 2004) 
such as VEGF, bFGF, Ang1 and Ang2 (Kamio et al., 2008, Smith et al., 2006). 
COX2 inhibition during vasodilator treatment gave a variable effect on muscle 
capillarity (7391%) but a similarly reduced femoral blood flow (7581%). Unlike 
NOS inhibition, however, the reduction in FBF following prostaglandin synthesis 
blockade cannot account for the large inhibitory action on angiogenesis. This 
indicates that a prostaglandin may have direct angiogenic actions in the capillary 
splitting phenotype, but that this varies depending on the vasodilatory mechanism 
involved (prazosin and cromakalim > verapamil and ethanol). However, the absence 
of a shear stimulus following NOS blockade suggests inhibition of not only the NO 
contribution of the flow stimulus, but also the prostaglandinmediated portion. Indeed, 
as there is considerable crosstalk between the two systems it is likely that inhibition 
of one vasodilator affects the other (Rubanyi et al., 1986) 
Coadministration of both LNNA and indomethacin was needed to effect a 
complete blockade of angiogenesis with ethanol and cromakalim, supporting the 
combined effect of NO and prostaglandin activity. Acute intravascular administration 
of cromakalim into rats led to a significant dose–dependent decrease in both mean 
arterial pressure and hindlimb perfusion pressure, an effect that was greatly reduced 
on blockade of NO production (Jahr et al., 1994). Interestingly, flow during ethanol 
and cromakalim treatments with NO blockade were at control levels, yet angiogenesis 
was observed. Ethanol has been shown to increase mRNA expression of a number of 
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growth factors and receptors in rat skeletal muscle at rest and after acute exercise, 
including VEGF, TGFβ1, bFGF and VEGFR1 (Gavin and Wagner, 2002). Induction 
of one or more of these may provide a compensatory angiogenic response, 
irrespective of a flow stimulus, although the form of angiogenesis induced is 
unknown. Clearly, changes in capillary supply with vasodilator treatment will alter 
the surface area for expression of EC markers, requiring some caution in 
interpretation of ‘whole muscle’ protein levels. However, laser microdissection of 
capillaries has been shown to generate parallel data to that derived from whole 
muscles (Milkiewicz and Haas, 2005), suggesting we may have confidence in the 
conclusions drawn. 
 
	
$"	 	
Having established a similar response to various vasodilators, suggesting that 
angiogenesis is due to mechanical forces associated with increased blood flow, 
though not necessarily in signalling mechanisms, we then used the most commonly 
used vasodilator to test whether such a response involves a turnover rate appropriate 
for previously detailed low mitotic activity. Prazosin may be a relatively selective 
vasodilator (Egginton, 2009) with little or no secondary angiogenic effects on the 
systemic vasculature (Hudlická, 1998), and results in angiogenesis within EDL that 
was complete by 4 wk of treatment (Williams et al., 2006a). The present study 
demonstrates that hindlimb blood flow increased with treatment duration, presumably 
resulting in a progressively greater angiogenic shear stress stimulus in the 
downstream microvasculature, likely inducing capillary splitting. In addition, 
arteriogenesis was evident by 4 wk prazosin treatment (data not shown) and it is 
likely that arteriolisation of capillaries, and terminal arteriole growth, allows better 
haemodynamic regulation of flow commensurate with increased capillarisation 
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(HansenSmith et al., 1998). A positive feedback loop involving decreased tissue 
resistance and increased blood flow may then follow. Femoral blood flow decreased 
by 25% within 1 wk of cessation of prazosin treatment, after which flow returned to 
normal values, consistent with regression of newly formed microvessels. As femoral 
blood flow reflects perfusion of all hindlimb muscles, the angiogenic profile of a large 
extensor muscle (EDL) may be indicative of a general response. Angiogenesis was 
complete by 2 wk prazosin treatment (above), and C:F returned toward control levels 
within 12 wk, indicating rapid capillary regression. The rapidity of growth without 
significant EC turnover indicates a nonproliferative expansion of the capillary bed, 
likely by elongation of existing microvessels. Given the presumed energyefficient 
reduced structural remodelling during expansion, it follows that regression may be 
less demanding than following sprouting and hence a similarly quick response is 
consistent with this form of capillary growth. 
 
	
	 	$*
In addition to the complexities of VEGF involvement (Wagner, 2011) the pro and 
antiangiogenic responses to short–term exercise and withdrawal have only recently 
been reported (Olenich et al., 2014, Hellsten and Hoier, 2014), but parallel studies on 
blood flow have not been conducted. 
 
1. VEGF expression is inversely related to blood flow 
Many studies report an upregulation of VEGF following both acute and chronic 
increases in shear stress (Da SilvaAzevedo et al., 2002) or muscle activity 
(Milkiewicz et al., 2005, Gavin and Wagner, 2002). Sequestration of this key 
angiogenic cytokine blocks angiogenesis in response to muscle overload and 
hyperaemia, both of which lead to a rise in VEGF levels 	 	 (Williams et al., 
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2006b). A rise in VEGF expression is reported within the first few days of prazosin 
treatment, followed by a reduction in protein levels after 4 wk (Egginton et al., 2011, 
Rivilis et al., 2002). A decline in VEGF levels on cessation of treatment would 
mediate microvascular regression in line with its antiapoptotic role (Ferrara, 2001). 
The present study used samples taken after the initial transient rise, so levels of VEGF 
declined in response to chronic prazosin treatment that continued after withdrawal, 
subsequently increasing after 14DR and reaching control levels only after 6 wk. This 
may be influenced by differences in blood oxygen supply, as VEGF synthesis is 
oxygendependent (Ferrara et al., 2003). Thus, a decrease in VEGF protein in the 
presence of prazosin may be a consequence of ‘luxury perfusion’ (Baum et al., 2004), 
with subsequent microvascular regression on cessation of prazosin treatment 
providing a resurgent drive for VEGF synthesis. While it is likely that hyperoxia, 
should it occur during hyperaemia, would not elicit the opposite response to hypoxia, 
delivery of oxygen at the microvascular level will be elevated by increased capillary 
perfusion, thereby increasing the PO2 gradient. However, this possibility requires 
further research as ‘sedentary’ mice selectively bred to have high aerobic exercise 
capacity with concomitant elevation in C:F compared to normal mice do not exhibit 
lower VEGF, but rather unchanged (or higher) basal VEGF protein (Audet et al., 
2011). 

2. Flk1 expression tracks changes in blood flow 
Extracellular growth factor receptors such as Flk1, the cognate receptor for VEGF 
predominantly expressed on endothelium and most associated with angiogenesis 
(Neufeld et al., 1999), are implicated in the shear stress response (Wang et al., 2002) 
where endothelial mechanotransduction modulates expression of shear stress 
responsive genes (Resnick et al., 1997). VEGF expression can increase in hypoxic 
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(Wang et al., 2007) and ischaemic (Milkiewicz et al., 2003) conditions, although in 
this study it is most likely to result from increases in shear stress. Flk1 upregulation 
is important 	 	 for the endothelium to withstand increases in shear stress 
(Conway and Schwartz, 2012) and higher levels after prazosin treatment may 
compensate for reduced ligand availability, with subsequent decreases likely tracking 
reduction in shear stress and augmented by capillary regression. Hence, a Flk1 
mediated, ligandindependent mechanotransduction may contribute more significantly 
to this form of angiogenesis than VEGF   (Wang et al., 2002, Baum et al., 2004), 
offering a parallel with the situation in lowflow ischaemia (Milkiewicz et al., 2004).  
 
3. Levels of eNOS are inversely related to levels of shear stress  
Increases in shear stress upregulates expression of the endothelialspecific isoform of 
NOS enzyme, hence prazosin treatment leads to activation of the eNOS gene 
(Williams et al., 2006c), and perhaps eNOS phosphorylation by a glycocalyxlinked 
deformation of caveolae (Pahakis et al., 2007).  Importantly, the present study 
demonstrates that a decreased shear stress after cessation of vasodilator therapy leads 
to a decrease in eNOS expression, a key mediator of shear stressinduced 
angiogenesis: vessel growth is absent in eNOS knockout mice (Williams et al., 
2006a). It may appear paradoxical that levels of VEGF decreases during significant 
blood vessel growth but eNOS upregulation increases NO production, which itself is 
angiogenic (Baum et al., 2004) so the downstream effects of NO may compensate for 
a decline in VEGF levels, e.g. angiogenesis appears to be NOdependent in ischaemic 
tissue (Murohara et al., 1998). Indeed, local paracrine interactions were evident in 
mice, where flowmediated endothelial stimulation of myocyte VEGF production was 
paralleled by myocytederived VEGF supporting microvascular remodelling(Uchida 
et al., 2015). 
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
4.  Complementary changes in angiopoietins 
Ang1 promotes vessel integrity through pericyte recruitment and endothelial 
quiescence by apoptosis suppression (Babaei et al., 2003, Carmeliet, 2003). Levels 
more than doubled after just 2 wk of prazosin treatment, but did not decline after the 
end of treatment. Proangiogenic effects of Ang1 have also been demonstrated in 
cultured coronary artery ECs (Chen et al., 2004) and subcutaneous Matrigel plugs 
(Babaei et al., 2003), dependent on the action of NO. Hence, an upregulation of Ang
1 in parallel with eNOS may stimulate blood vessel growth, while any decline may 
contribute to prevention of EC apoptosis, but 		 changes are modest compared 
with those expected from 	 	 studies. Ang2 displays pleiotropic, VEGF
dependent effects that promote microvascular growth, as Ang2/Tie2 interactions 
destabilise the endothelium (Hanahan, 1997). Again, 	 	 studies suggest that 
elevated shear stress downregulates Ang2 expression (Goettsch et al., 2008), but the 
levels of shear used were not physiological and may reflect EC dysfunction. 
However, we saw no significant change in Ang2 levels during angiogenesis or 
microvessel regression (data not shown), also little or no change in expression of its 
cognate receptor, Tie2. These findings suggest that, in physiological shearinduced 
angiogenesis, Ang2 elevation may be unnecessary in the presence of proangiogenic 
Ang1 levels. In the absence of angiopoietin stimulation, therefore, the levels of Tie2 
may be ‘diluted’ on EC expansion relative to other EC markers, such as Flk1. 
 
5. Prolonged depression of an antiangiogenic factor 
TSP1 is downregulated in response to increases in shear (Bongrazio et al., 2006), 
and, when complexed with its receptor, CD36, inhibits VEGFR2 (Chu et al., 2013). 
This reduces angiogenesis readouts 		(Klenotic et al., 2013) and 		 (Audet 
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et al., 2013). As in this study, a downregulation of proangiogenic factors has 
previously been seen during muscle denervation and capillary regression (Wagatsuma 
et al., 2005), but antiangiogenic factors such as the thrombospondins may also play a 
role in maintaining an effective control of capillary growth (Olfert et al., 2006). 
Changes in capillarisation are then dependent on the balance between pro and anti
angiogenic factors (Carmeliet, 2003), consistent with the lack of a rebound rise in 
TSP1 after cessation of vasodilator treatment. However, capillary rarefaction from 
basal levels may represent a different (pathological) context than capillary regression 
to basal levels after (physiological) capillary growth, likely representing active 
signalling and withdrawal of signal, respectively. 
 
$		"	  	
Vasodilatorinduced angiogenesis occurs in response to mechanical forces associated 
with increased blood flow, i.e. is not a chemotransductive response. An elevated 
microvascular shear stress using common vasodilators increases muscle C:F to a 
similar extent, allowing us to examine the mechanotransductive response, including 
evidence for alteredexpression of pro and antiangiogenic proteins. Further 
alterations in protein expression associated with capillary regression occur when the 
vasodilator is withdrawn. Interestingly, NO or COX inhibitors prevented the effects of 
vasodilators on C:F, although these pathways are not solely responsible for 
vasodilatation. An increase in C:F paralleled that of FBF, suggesting both arteriogenic 
and angiogenic components of an integrated response to elevated shear stress, while 
subsequent reduction leads to vessel regression, supporting the contention that 
angiogenesis is induced by mechanotransduction following elevated shear stress. A 
conceptual summary of the main findings is provided (Suppl. Fig. 1).
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Posttranscriptional modification of proteins may be required before they become 
biologically active, cytokines may be stored intracellularly as inactive precursors until 
phosphorylated (Goettsch et al., 2008) (Ferrara, 2001), and VEGF supplementation is 
ineffective in the absence of eNOS (Murohara et al., 1998). Hence, further studies are 
required to document mechanistic regulation		. A brief temporal delay between 
modulation of mRNA expression and an identifiable change in protein levels is to be 
expected. However, The biological effects continued for some time after treatment 
ended, e.g. FBF and VEGF levels, likely due to prazosin clearance time and kinetics 
of tissue remodelling. Prolonged increases in blood flow and shearing forces may 
perpetuate the proteomic response, while structural changes accompanying 
microvascular expansion or regression likely outlast the biochemical effects of 
chronic vasodilatation. 
 
		  		
An increase in shear stress is one of the many factors thought to induce blood vessel 
growth in response to exercise (Prior et al., 2004), including signals effective over 
different time courses such as altered enzymatic activity (Mujika and Padilla, 2001) 
and mechanical stretch (Prior et al., 2004, Williams et al., 2006a). While VEGF 
expression decreases following prazosininduced chronic hyperaemia, it rises during 
acute increases in blood flow associated with periods of activity (Prior et al., 2004). 
During periods of disuse regression of capillaries is associated with muscle atrophy 
(Dedkov et al., 2002), despite reduced vasomotor tone (Tyml et al., 1999). Increased 
blood flow reduces the extent of capillary regression, such that maintenance of blood 
flow during periods of inactivity may attenuate the extent of microvascular 
rarefaction, hence exercise regimes are important during periods of bed rest and 
spaceflight (Trappe et al., 2001). Supplementation of different growth factors may 
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provide acute benefit during recovery from surgery, especially if exercise is not 
possible, but risk side effects. Alternative therapies could involve controlled use of 
vasodilators, as rapidity of response predicted from an energetically efficient (low EC 
mitosis) form of angiogenesis offers temporal selectivity. NO supplementation, 
manipulation of the eNOS/NO system or Ang1 and Flk1 may also be effective. 
VEGF treatment may be contraindicated in this scenario, as its effect on vascular 
permeability produces oedema (Ferrara, 2001), but suppression of thromobospondin 1 
may be beneficial. 
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Supplementary Table 1. 

Group  Femoral flow Blood pressure Heart rate  
  (ml/min) (mmHg)  (min1) 
 
Control  0.40±0.012 91.3±3.26  311±38.9 
Prazosin 2d  0.51±0.043 99.0±1.16  257±19.5 
Prazosin 4d  0.48±0.019 82.3±2.56  306±13.8 
Prazosin 7d  0.54±0.075 93.5±3.40  310±25.5 
Prazosin 14d  0.57±0.029 88.5±3.29  360±16.6 
Prazosin 28d  0.61±0.024 90.2±4.18  342±22.8 
1wk regression 0.54±0.010 87.1±4.14  296±18.0 
2wk regression 0.44±0.026 86.0±3.85  289±15.5 
6wk regression 0.40±0.020 84.3±2.33  248±23.3 
 
NB. Given that mice consume ~3 ml of water each day, this equates to ~150 µg of 
prazosin daily, a dose known to stimulate shear stressinduced angiogenesis in both 
rats and mice (Hudlická, 1998) (Baum et al., 2004).  
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Figure 1.  (A) Femoral blood flow after 14 d chronic vasodilator treatment. (B) C:F in 
EDL of mice after 14 d chronic vasodilator treatment. The latter estimate used a 
270x270µm counting square and an unbiased sampling protocol, aiming for at least 
50 fibres or 100 capillaries to minimise statistical errors (Egginton, 1990a, Egginton, 
1990b). Mean±SEM (n=6). ** +<0.01 . control. Abbreviations: FBF, femoral blood 
flow; C:F, capillary to fibre ratio; Cont, control; Praz, prazosin; Ver, verapamil; 
Crom, cromakalim; Eth, ethanol.
 
Figure 2.  Individual femoral flow - C:F values showing a positive correlation 
among animals; controls are circled (R2= 0.8412; Y=1.752*X+0.5330) 
 
Figure 3. Left panel: C:F after 14 d chronic vasodilator treatment with blockade of 
NO and prostaglandin production. Mean±SEM (n=6). *+<0.05 and **+<0.001 - 
control, 
+
+<0.05 and 
++
+<0.001 - vasodilator alone. Abbreviations: P, prazosin; V, 
verapamil; C, cromakalim; E, ethanol; LNNA, NwnitroLarginine; Indo, 
indomethacin. Right panel: Example micrographs of lectin stained cryosections for i) 
control, ii) control + LNNA, iii) prazosin, iv) prazosin + LNNA, v) verapamil, vi) 
ethanol, vii) cromakalim, viii) cromakalim + LNNA. Scale bar = 150µm. 

Figure 4. Femoral blood flow (solid line) and C:F before and during chronic prazosin 
treatment (open bars), and 16 wk after cessation of treatment (hatched bars). 
Mean±SEM (n=6). The evident relationship between blood flow and capillarisation is 
quantified as follows: angiogenesis Cont – 28DP r=0.877; regression 7DR42DR 
r=0.896. FBF: *+<0.05 . control, **+<0.01 . control, ***+<0.001 . control, 
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+
+<0.05 . prazosin 14 d and 28 d. C:F #+<0.05 . control, $+<0.05 . prazosin 14 
d and 28 d.  Abbreviations: DP, days of prazosin treatment; DR, days since prazosin 
removal.
 
Figure 5. Relative protein expression for VEGF (triangle), Flk1 (square) and eNOS 
(filled circle) in mouse EDL over 4 wk prazosin treatment, and 6 wk recovery, 
correlated with femoral blood flow (open circle). Densitometry values were 
referenced to total protein content, and individual protein levels expressed in arbitrary 
units (AU). *+<0.05, **+<0.01, ***+<0.001 - control (FBF). $, + and # +<0.05 - 
control (Flk1, VEGF and eNOS, respectively). 7 some error bars are contained 
within the symbols. Abbreviations: WP, weeks of prazosin treatment. 
 
Figure 6. Changes in Tie2, Ang1 and TSP1 protein levels in mouse EDL during 
angioadaptation. Note different scale to Fig. 5. *+<0.05 - control (TSP1).


Supplementary Figure 1. Conceptual summary of the study design and main findings.

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(A) Femoral blood flow after 14 d chronic vasodilator treatment. (B) C:F in EDL of mice after 14 d chronic 
vasodilator treatment. The latter estimate used a 270x270µm counting square and an unbiased sampling 
protocol, aiming for at least 50 fibres or 100 capillaries to minimise statistical errors (Egginton, 1990a, 
Egginton, 1990b). Mean±SEM (n=6). ** P<0.01 vs. control. Abbreviations: FBF, femoral blood flow; C:F, 
capillary to fibre ratio; Cont, control; Praz, prazosin; Ver, verapamil; Crom, cromakalim; Eth, ethanol.  
508x381mm (72 x 72 DPI)  
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Right panel: Example micrographs of lectin stained cryosections for i) control, ii) control + LNNA, iii) 
prazosin, iv) prazosin + LNNA, v) verapamil, vi) ethanol, vii) cromakalim, viii) cromakalim + LNNA. Scale 
bar = 150µm.  
508x381mm (72 x 72 DPI)  
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